Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “CTOR”

756 pharma patents match "CTOR" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 756
Index total 30,257
Page 23 / 32

Quick answer

This filtered view shows 756 pharmaceutical patents matching "CTOR" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

756 results for “CTOR” · 30,257 patents in full index Clear search

  1. US 7922999

    Administration of growth factors for the treatment of CNS disorders

    The Regents of the University of California · Granted Apr 12, 2011 · Expires Apr 7, 2031

    granted

  2. US 7919301

    Recovery of recombinant human parainfluenza virus type 2 (HPIV2) from CDNA and use of recombinant HPIV2 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 5, 2011 · Expires Mar 31, 2031

    granted

  3. US 7919583

    Integration-site directed vector systems

    Discovery Genomics, Inc. · Granted Apr 5, 2011 · Expires Mar 31, 2031

    granted

  4. US 7892008

    Electrical connector having metallic lock

    Hon Hai Precision Ind. Co., Ltd. · Granted Feb 22, 2011 · Expires Feb 17, 2031

    granted

  5. US 7893299

    Interleukin-1 and tumor necrosis factor-αmodulators; syntheses of such modulators and methods of using such modulators

    The Regents of the University of California · Granted Feb 22, 2011 · Expires Feb 17, 2031

    granted

  6. US 7888069

    Plant-made west nile virus (WNV) vaccines, vectors and plant codon optimized sequences

    The United States of America as represented by the Secretary of Argriculture · Granted Feb 15, 2011 · Expires Feb 10, 2031

    granted

  7. US 7884178

    Griffithsin, glycosylation-resistant griffithsin, and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of use

    The United States of America, as represented by the Department of Health and Human Services · Granted Feb 8, 2011 · Expires Feb 3, 2031

    granted

  8. US 7871985

    Compositions and methods for inhibiting expression of factor VII gene

    Alnylam Pharmaceuticals, Inc. · Granted Jan 18, 2011 · Expires Jan 13, 2031

    granted

  9. US 7867500

    Cofactor that modulates steroid receptor activities

    The United States of America, as represented by the Department of Health and Human Services · Granted Jan 11, 2011 · Expires Jan 6, 2031

    granted

  10. US 7867974

    Induction of tolerance by oral administration of factor VIII and treatment of hemophilia

    The United States of America, as represented by the Department of Health and Human Services · Granted Jan 11, 2011 · Expires Jan 6, 2031

    granted

  11. US 7863041

    Rabies virus vector systems and compositions and methods thereof

    The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Jan 4, 2011 · Expires Dec 30, 2030

    granted

  12. US 7863421

    Polymer-factor VIII moiety conjugates

    Nektar Therapeutics · Granted Jan 4, 2011 · Expires Dec 30, 2030

    granted

  13. US 7858749

    Polymer-factor VIII moiety conjugates

    Nektar Therapeutics · Granted Dec 28, 2010 · Expires Dec 23, 2030

    granted

  14. US 7820181

    Recovery of recombinant human parainfluenza virus type 2 (HPIV2) from cDNA and use of recombinant HPIV2 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens

    The United States of America, as represented by the Department of Health and Human Services · Granted Oct 26, 2010 · Expires Oct 21, 2030

    granted

  15. US 7776564

    Stromal cell-derived factor-1 polypeptides, polynucleotides, modulators thereof and methods of use

    Five Prime Therapeutics, Inc. · Granted Aug 17, 2010 · Expires Aug 12, 2030

    granted

  16. US 7776320

    Methods for therapeutic use of brain derived neurotrophic factor in the entorhinal cortex

    The Regents of the University of California · Granted Aug 17, 2010 · Expires Aug 12, 2030

    granted

  17. US 7771729

    Methods of potentiating HIV-1-specific CD8+ immune responses involving the concomitant administration of DNA and ALVAC expression vectors

    The United States of America, as represented by the Department of Health and Human Services · Granted Aug 10, 2010 · Expires Aug 5, 2030

    granted

  18. US 7771715

    Recombinant vector expressing multiple costimulatory molecules and uses thereof

    The United States of America, as represented by the Department of Health and Human Services · Granted Aug 10, 2010 · Expires Aug 5, 2030

    granted

  19. US 7759304

    Targeting complement factor H for treatment of diseases

    The Regents of the University of Colorado · Granted Jul 20, 2010 · Expires Jul 15, 2030

    granted

  20. US 7745406

    Fibroblast growth factor (FGF23) polypeptides

    Ludwig-Maximilians-Universitat Munchen Abeteilung Mediziniche Genetik · Granted Jun 29, 2010 · Expires Jun 24, 2030

    granted

  21. US 7718424

    AAV4 vector and uses thereof

    The United States of America, as represented by the Department of Health and Human Services · Granted May 18, 2010 · Expires May 13, 2030

    granted

  22. US 7718428

    Myeloid colony stimulating factor and uses thereof

    HALOZYME, INC. · Granted May 18, 2010 · Expires May 13, 2030

    granted

  23. US 7717728

    Electrical Connector

    Advanced Connectek Inc. · Granted May 18, 2010 · Expires May 13, 2030

    granted

  24. US 7704509

    Recovery of recombinant human parainfluenza virus type 1 (HPIV1) from cDNA and use of recombinant HPIV1 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens

    The United States of America · Granted Apr 27, 2010 · Expires Apr 22, 2030

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.